The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.
The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.
复制标题
米曲宁的呼吸抑制作用因其转化为7-羟基米曲宁而受到限制。
DOI:
10.1111/bph.15832
复制
发表时间:
2022-07
影响因子:
7.3
通讯作者:
中科院分区:
文献类型:
--
作者:
Mitragynine, the major alkaloid in Mitragyna speciosa (kratom), is a partial agonist at the μ opioid receptor. CYP3A‐dependent oxidation of mitragynine yields the metabolite 7‐OH mitragynine, a more efficacious μ receptor agonist. While both mitragynine and 7‐OH mitragynine can induce anti‐nociception in mice, recent evidence suggests that 7‐OH mitragynine formed as a metabolite is sufficient to explain the anti‐nociceptive effects of mitragynine. However, the ability of 7‐OH mitragynine to induce μ receptor‐dependent respiratory depression has not yet been studied. Respiration was measured in awake, freely moving, male CD‐1 mice, using whole body plethysmography. Anti‐nociception was measured using the hot plate assay. Morphine, mitragynine, 7‐OH mitragynine and the CYP3A inhibitor ketoconazole were administered orally. The respiratory depressant effects of mitragynine showed a ceiling effect, whereby doses higher than 10 mg·kg−1 produced the same level of effect. In contrast, 7‐OH mitragynine induced a dose‐dependent effect on mouse respiration. At equi‐depressant doses, both mitragynine and 7‐OH mitragynine induced prolonged anti‐nociception. Inhibition of CYP3A reduced mitragynine‐induced respiratory depression and anti‐nociception without affecting the effects of 7‐OH mitragynine. Both the anti‐nociceptive effects and the respiratory depressant effects of mitragynine are partly due to its metabolic conversion to 7‐OH mitragynine. The limiting rate of conversion of mitragynine into its active metabolite results in a built‐in ceiling effect of the mitragynine‐induced respiratory depression. These data suggest that such ‘metabolic saturation’ at high doses may underlie the improved safety profile of mitragynine as an opioid analgesic.
登录
查看更多内容
影响因子:
6.7
作者:
Crews KR;Monte AA;Huddart R;Caudle KE;Kharasch ED;Gaedigk A;Dunnenberger HM;Leeder JS;Callaghan JT;Samer CF;Klein TE;Haidar CE;Van Driest SL;Ruano G;Sangkuhl K;Cavallari LH;Müller DJ;Prows CA;Nagy M;Somogyi AA;Skaar TC
通讯作者:
Skaar TC
DOI:
10.1038/npp.2015.201
发表时间:
2016-02
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
Hill R;Lyndon A;Withey S;Roberts J;Kershaw Y;MacLachlan J;Lingford-Hughes A;Kelly E;Bailey C;Hickman M;Henderson G
通讯作者:
Henderson G
影响因子:
7.3
作者:
Chakraborty S;Uprety R;Slocum ST;Irie T;Le Rouzic V;Li X;Wilson LL;Scouller B;Alder AF;Kruegel AC;Ansonoff M;Varadi A;Eans SO;Hunkele A;Allaoa A;Kalra S;Xu J;Pan YX;Pintar J;Kivell BM;Pasternak GW;Cameron MD;McLaughlin JP;Sames D;Majumdar S
通讯作者:
Majumdar S
影响因子:
7.3
作者:
Hill R;Disney A;Conibear A;Sutcliffe K;Dewey W;Husbands S;Bailey C;Kelly E;Henderson G
通讯作者:
Henderson G
影响因子:
2.5
作者:
Basiliere, Stephanie;Kerrigan, Sarah
通讯作者:
Kerrigan, Sarah